CAR T play Legend looks to lead trio of biotechs onto NASDAQ

Look for three biotechs to price IPOs on NASDAQ this week, with CAR T company Legend the headliner.

The Nanjing-based company, which is spinning out of GenScript Biotech Corp. (HKSE:1548), aims to raise $350 million in an offering on NASDAQ that, if priced at the mid-point of its $18-$20 price range, would value the company at $2.5 billion. The deal is expected to price on Friday...